Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format

Background: The COVID-19 pandemic has brought to light both challenges and unique opportunities regarding type 1 diabetes (T1D) management, including the usage of telemedicine platforms. Methods: This study was conducted in a tertiary hospital diabetes clinic. All consecutive T1D patients during Mar...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tal Schiller, Taiba Zornitzki, Viviana Ostrovsky, Danielle Sapojnik, Lee Cohen, Tamila Kunyavski, Hilla Knobler, Alena Kirzhner
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	telemedicine type 1 diabetes remote consultation virtual medicine Medicine R
Acceso en línea:	https://doaj.org/article/b1a7d355e6c24b4d8f5b05ab97b18f9a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b1a7d355e6c24b4d8f5b05ab97b18f9a
record_format	dspace
spelling	oai:doaj.org-article:b1a7d355e6c24b4d8f5b05ab97b18f9a2021-11-11T16:27:27ZFollowing the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format10.3390/ijerph1821113091660-46011661-7827https://doaj.org/article/b1a7d355e6c24b4d8f5b05ab97b18f9a2021-10-01T00:00:00Zhttps://www.mdpi.com/1660-4601/18/21/11309https://doaj.org/toc/1661-7827https://doaj.org/toc/1660-4601Background: The COVID-19 pandemic has brought to light both challenges and unique opportunities regarding type 1 diabetes (T1D) management, including the usage of telemedicine platforms. Methods: This study was conducted in a tertiary hospital diabetes clinic. All consecutive T1D patients during March and June 2021 were asked to fill out a structured anonymous questionnaire that aimed to determine their preference regarding continuous use of a virtual platform. Results: In total, 126 T1D patients answered the questionnaire, of whom 51% were under the age of 40, half were men, half used insulin pumps, and 69% used continuous glucose monitoring. During the pandemic, the exposure of patients to virtual visits has grown about twofold, from 29% to 53%. Of the respondents, 49% expressed an interest in future usage of a virtual platform, but most of them preferred use in a hybrid manner. We found an association between preference to use telemedicine in the future and younger age, previous virtual platform experience, and confidence in being able to download data. Conclusions: Our data demonstrate that the COVID-19 experience has led to a growing interest of T1D patients in using the hybrid format of telemedicine. However, we still need to better understand who will benefit most from this platform and assess its cost-effectiveness and organization.Tal SchillerTaiba ZornitzkiViviana OstrovskyDanielle SapojnikLee CohenTamila KunyavskiHilla KnoblerAlena KirzhnerMDPI AGarticletelemedicinetype 1 diabetesremote consultationvirtual medicineMedicineRENInternational Journal of Environmental Research and Public Health, Vol 18, Iss 11309, p 11309 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	telemedicine type 1 diabetes remote consultation virtual medicine Medicine R
spellingShingle	telemedicine type 1 diabetes remote consultation virtual medicine Medicine R Tal Schiller Taiba Zornitzki Viviana Ostrovsky Danielle Sapojnik Lee Cohen Tamila Kunyavski Hilla Knobler Alena Kirzhner Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format
description	Background: The COVID-19 pandemic has brought to light both challenges and unique opportunities regarding type 1 diabetes (T1D) management, including the usage of telemedicine platforms. Methods: This study was conducted in a tertiary hospital diabetes clinic. All consecutive T1D patients during March and June 2021 were asked to fill out a structured anonymous questionnaire that aimed to determine their preference regarding continuous use of a virtual platform. Results: In total, 126 T1D patients answered the questionnaire, of whom 51% were under the age of 40, half were men, half used insulin pumps, and 69% used continuous glucose monitoring. During the pandemic, the exposure of patients to virtual visits has grown about twofold, from 29% to 53%. Of the respondents, 49% expressed an interest in future usage of a virtual platform, but most of them preferred use in a hybrid manner. We found an association between preference to use telemedicine in the future and younger age, previous virtual platform experience, and confidence in being able to download data. Conclusions: Our data demonstrate that the COVID-19 experience has led to a growing interest of T1D patients in using the hybrid format of telemedicine. However, we still need to better understand who will benefit most from this platform and assess its cost-effectiveness and organization.
format	article
author	Tal Schiller Taiba Zornitzki Viviana Ostrovsky Danielle Sapojnik Lee Cohen Tamila Kunyavski Hilla Knobler Alena Kirzhner
author_facet	Tal Schiller Taiba Zornitzki Viviana Ostrovsky Danielle Sapojnik Lee Cohen Tamila Kunyavski Hilla Knobler Alena Kirzhner
author_sort	Tal Schiller
title	Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format
title_short	Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format
title_full	Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format
title_fullStr	Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format
title_full_unstemmed	Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format
title_sort	following the covid-19 experience, many patients with type 1 diabetes wish to use telemedicine in a hybrid format
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/b1a7d355e6c24b4d8f5b05ab97b18f9a
work_keys_str_mv	AT talschiller followingthecovid19experiencemanypatientswithtype1diabeteswishtousetelemedicineinahybridformat AT taibazornitzki followingthecovid19experiencemanypatientswithtype1diabeteswishtousetelemedicineinahybridformat AT vivianaostrovsky followingthecovid19experiencemanypatientswithtype1diabeteswishtousetelemedicineinahybridformat AT daniellesapojnik followingthecovid19experiencemanypatientswithtype1diabeteswishtousetelemedicineinahybridformat AT leecohen followingthecovid19experiencemanypatientswithtype1diabeteswishtousetelemedicineinahybridformat AT tamilakunyavski followingthecovid19experiencemanypatientswithtype1diabeteswishtousetelemedicineinahybridformat AT hillaknobler followingthecovid19experiencemanypatientswithtype1diabeteswishtousetelemedicineinahybridformat AT alenakirzhner followingthecovid19experiencemanypatientswithtype1diabeteswishtousetelemedicineinahybridformat
_version_	1718432316828680192

Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format

Ejemplares similares